Novel biomarkers may provide guide to personalized hepatitis C therapy
Wednesday, May 13, 2015 - 13:30
in Health & Medicine
A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report. Hepatitis C chronically infects about 160 million people worldwide, and is a major cause of illness and death from hepatocellular carcinoma and end-stage liver disease.